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INFUTURIA GLOBAL LTD. v. 
SEQUUS PHARMACEUTICALS, 
INC.: THE BREADTH OF REMOVAL 
JURISDICTION UNDER         
9 U.S.C. § 205 
CONOR BURDEN LEONARD*
INTRODUCTION
In Infuturia Global Ltd. v. Sequus Pharmaceuticals, Inc., the U.S. 
Court of Appeals for the Ninth Circuit analyzed the scope of federal 
removal jurisdiction over matters related to certain international 
arbitration agreements and awards.1  In doing so, the Ninth Circuit 
articulated a broad standard to determine whether a federal court is an 
appropriate forum to hear a dispute related to a foreign arbitration 
agreement or award.2  The Ninth Circuit interpreted the key language of 
the relevant provision to permit removal whenever there is an arbitral 
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1 Infuturia Global Ltd. v. Sequus Pharm., Inc. (Infuturia II), 631 F.3d 1133, 1135, 1138-39 
(9th Cir. 2011). 
2 Id. at 1135. 
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award or agreement that “could conceivably affect the outcome of the 
plaintiff’s suit.”3
I.  BACKGROUND
Arbitration is a method of nonjudicial dispute resolution usually 
governed by a judicially enforceable agreement to submit specified 
issues to private resolution by a third party.4  It provides the parties with 
an opportunity to choose a convenient forum,5 control the characteristics 
of the neutral third party,6 and avoid prolonged litigation.7  In this way, 
arbitration can reduce the expenses associated with extended litigation.8
Despite the advantages of arbitration, English courts initially held a 
negative view of arbitration.9  U.S. courts originally followed the English 
viewpoint toward arbitration until Congress passed the Federal 
Arbitration Act of 1925 (FAA).10  The FAA11 effectively reversed 
American courts’ animosity toward arbitration and “created a powerful 
federal policy in favor of [it].”12  More specifically, Congress sought to 
further American business interests through arbitration with the 
Convention on the Recognition and Enforcement of Foreign Arbitral 
Awards, which is a chapter of the FAA.13
Congress promoted arbitration through the Convention in a few 
ways.  First, Congress established a quid pro quo with international 
governments related to arbitral awards and agreements.14  A U.S. district 
3 Id.
4 Wolsey, Ltd. v. Foodmaker, Inc., 144 F.3d 1205, 1207–09 (9th Cir. 1998); see Stolt-
Nielsen S.A. v. AnimalFeeds Int’l Corp., 130 S. Ct. 1758, 1773-74 (2010). 
5 Susan L. Karamanian, The Road to the Tribunal and Beyond: International Commercial 
Arbitration and United States Courts, 34 GEO. WASH. INT’L L. REV. 17, 17 (2002). 
6 See Stolt-Nielsen, 130 S. Ct. at 1775; see also Terry L. Trantina, An Attorney’s Guide to 
Alternative Dispute Resolution (ADR): “ADR 1.01”, 1102 PLI/ CORP 29, 38 (1999). 
7 Southland Corp. v. Keating, 465 U.S. 1, 7 (1984). 
8 Mitsubishi Motors Corp. v. Soler Chrysler-Plymouth, Inc., 473 U.S. 614, 633 (1985). 
9 Scherk v. Alberto-Culver Co., 417 U.S. 506, 510 n.4 (1974); see also Deborah Travis, 
Broker Churning: Who Is Punished? Vicariously Assessed Punitive Damages in the Context of 
Brokerage Houses and Their Agents, 30 HOUS. L. REV. 1775, 1784 (1993) [hereinafter Travis, 
Broker Churning] (discussing the history of the FAA). 
10 Scherk, 417 U.S. at 510 n.4; see also Travis, Broker Churning, 30 HOUS. L. REV. at 1784 
(discussing the history of the FAA). 
11 Federal Arbitration Act of 1925, Pub. L. No. 68-401, 43 Stat. 883 (1925) (codified at 9 
U.S.C. §§ 1-16). 
12 Travis, Broker Churning, 30 HOUS. L. REV. at 1784 (discussing the history of the FAA). 
13 9 U.S.C.A. §§ 201-208 (Westlaw 2011); H.R. REP. NO. 91-1181, at 1 (1970), reprinted in
1970 U.S.C.C.A.N. 3601, 3602. 
14 Defining quid pro quo as “[a]n action or thing that is exchanged for another action or thing 
of more or less equal value; a substitute.” BLACK’S LAW DICTIONARY 1367 (9th ed. 2009); 
2
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court must order arbitration when (a) the arbitral agreement is in writing, 
(b) the arbitration is to take place in a country that signed the 
Convention, (c) the arbitral agreement arises out of a legal relationship, 
and (d) one of the parties to the agreement is not an American citizen.15
Second, Congress granted original jurisdiction to the district courts to 
adjudicate arbitral disputes “falling under the Convention.”16
Various Convention sections deal with other specifics.  For 
instance, they identify the types of agreements that fall under the 
Convention and create causes of action to enforce them.17  Specifically, 9 
U.S.C. §§ 206 and 207 allow a party to sue in federal court to compel 
arbitration or to confirm an arbitral award stemming from a Convention 
agreement.18  In addition, 9 U.S.C. § 205 provides for removal of an 
action on a foreign arbitral award to the appropriate U.S. district court.19
In Infuturia Global Ltd. v. Sequus Pharmaceuticals, Inc., the Ninth 
Circuit determined whether the U.S. District Court for the Northern 
District of California had jurisdiction over an action removed from state 
court by the defendant.20  The Ninth Circuit evaluated two different 
viewpoints of the language of § 205.  The Fifth Circuit, the only other 
circuit to evaluate the language of § 205 that authorizes removal of an 
action that “relates to” an arbitration agreement or award falling under 
the Convention, interpreted the phrase to permit removal “whenever an 
arbitration agreement falling under the Convention could conceivably
affect the outcome of the plaintiff’s case.”21  In contrast to the Fifth 
Circuit’s decision on the scope of § 205 removal, a Central District of 
California decision narrowed the scope of the statute by adding privity of  
McDermott Int’l, Inc. v. Lloyds Underwriters of London, 944 F.2d 1199, 1207-08 (5th Cir. 1991). 
15 Sedco, Inc. v. Petroleos Mexicanos Mexican Nat’l Oil Co., 767 F.2d 1140, 1144-45 (5th 
Cir. 1985). 
16 9 U.S.C.A. § 203 (Westlaw 2011). 
17 9 U.S.C.A. §§ 202, 206, 207 (Westlaw 2011); Czarina, L.L.C. v. W.F. Poe Syndicate, 358 
F.3d 1286, 1290-91 (11th Cir. 2004). 
18 9 U.S.C.A. §§ 206, 207; Czarina L.L.C., 358 F.3d at 1290-91. 
19 9 U.S.C.A. § 205 (Westlaw 2011). 
20 Infuturia Global Ltd. v. Sequus Pharm., Inc. (Infuturia II), 631 F.3d 1133, 1135 (9th Cir. 
2011); see 9 U.S.C.A. § 205 (providing that “[w]here the subject matter of an action or proceeding 
pending in a State court relates to an arbitration agreement or award falling under the Convention, 
the defendant . . . may . . . remove such action or proceeding to the district court of the United 
States” (emphasis added)). 
21 Beiser v. Weyler, 284 F.3d 665, 669 (5th Cir. 2002), quoted in Infuturia II, 631 F.3d at 
1137-38. 
3
Leonard: Infuturia Global Ltd. v. Sequus Pharmaceuticals, Inc.
Published by GGU Law Digital Commons, 2012
140 GOLDEN GATE UNIVERSITY LAW REVIEW [Vol. 42 
contract as a prerequisite.22  The Ninth Circuit settled on the broader 
interpretation.23
The decision is noteworthy because it provides parties engaged in 
international disputes with ready access to the federal courts.  The Ninth 
Circuit stated that the federal courts have jurisdiction over certain 
international arbitral agreements and awards whenever the agreement or 
award “‘relates to’ the subject matter of an action . . . [that] could 
conceivably affect the outcome of the plaintiff’s suit.”24  This broad 
interpretation of § 205, coupled with other factors, will make it easier for 
parties to access a federal forum in arbitration disputes. 
II.  FACTS OF INFUTURIA GLOBAL LTD. V. SEQUUS PHARMACEUTICALS,
INC.
Infuturia Global Ltd. v. Sequus Pharmaceuticals, Inc., involved five 
parties.  Plaintiff-appellant Infuturia Global Ltd. (Infuturia), a citizen of 
the British Virgin Islands, developed and marketed liposome-related 
pharmaceutical products.25  Defendant-appellee Sequus Pharmaceuticals 
Inc., (Sequus), a California pharmaceutical company, produced lipid-
based drugs.26  Defendant Professor Yechezkel Barenholz was an Israeli 
citizen and an employee of defendant Hebrew University, an Israeli 
corporation.27  Yissum Research and Development Company of the 
Hebrew University of Jerusalem (Yissum), an Israeli company,28 was the 
subsidiary that protected intellectual property created by University 
students and faculty.29
In 1990, Infuturia and Yissum entered into a license agreement (the 
1990 agreement) that gave Infuturia an exclusive license related to 
certain liposome-based technology developed by Barenholz.30  An 
arbitration clause in the 1990 agreement mandated “arbitration of any 
22 AtGames Holdings Ltd. v. Radica Games Ltd., 394 F. Supp. 2d 1252, 1255-56 (C.D. Cal. 
2005) (order granting motion to remand), overruled by Infuturia II, 631 F.3d at 1138-39; Infuturia II,
631 F.3d at 1138-39. 
23 Infuturia II, 631 F.3d at 1138-39. 
24 Id. at 1135. 
25 Infuturia Global Ltd. v. Sequus Pharm., Inc. (Infuturia I), No. C 08-4871 SBA, 2009 WL 
440477, at *1 (N.D. Cal. Feb. 23, 2009) (order denying motion to remand), aff’d, 631 F.3d 1133 (9th 
Cir. 2011); Infuturia II, 631 F.3d at 1135. 
26 Infuturia I, 2009 WL 440477, at *1; Infuturia II, 631 F.3d at 1135. 
27 Infuturia I, 2009 WL 440477, at *1. 
28 Brief for Appellee at 5, Infuturia II, 631 F.3d 1133 (No. 09-16378), 2009 WL 7113238 at 
*5. 
29 Infuturia I, 2009 WL 440477, at *1; Infuturia II, 631 F.3d at 1135. 
30 Infuturia I, 2009 WL 440477, at *1; U.S. Patent No. 4,812,314 (filed Feb. 24, 1986). 
4
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dispute ‘connected in any way to the implementation of [the] 
Agreement.’”31  Five years later, Sequus entered into a license agreement 
(the 1995 agreement) with Yissum.32  The 1995 agreement also covered 
liposome technology rights.33  Not long thereafter, a lawsuit ensued.34
III.  THE ISSUE AND PROCEDURAL HISTORY OF INFUTURIA GLOBAL LTD.
V. SEQUUS PHARMACEUTICALS, INC.
The dispute in Infuturia Global arose over licensing rights owned 
by Yissum.35  Infuturia sued Sequus, the University, and Barenholz in 
Santa Clara County Superior Court, alleging tortious interference with 
the 1990 agreement.36  Infuturia claimed that discoveries that should 
have been reported to it under the 1990 agreement were licensed instead 
to Sequus.37  Citing the arbitration clause in the 1990 agreement, non-
party Yissum sought a stay of the Santa Clara County Superior Court 
litigation and an order to compel arbitration in Israel.38  The court 
granted the stay, and the case went to arbitration.39
In arbitration, Yissum and Infuturia brought claims against each 
other.40  Yissum alleged that Infuturia owed it $125,000 under the 1990 
agreement and that Infuturia’s failure to pay allowed Yissum to cancel 
the 1990 agreement.41  Infuturia alleged that Yissum breached the 1990 
agreement when it shared information with Sequus that sparked the 
development of a cancer drug, and that Yissum owed Infuturia $45 
million.42





36 Joint Case Management Statement at 5, Infuturia Global Ltd. v. Sequus Pharm., Inc., 2009 
WL 440477 (N.D. Cal. May 26, 2009) (No. C 08-4871 SBA), 2009 WL 1948894 at *2, *5; 
Answering Brief of Defendant-Appellee, Infuturia II, 631 F.3d 1133 (No. 09-16378), 2009 WL 
7113238 at *2; Infuturia Global Ltd. v. Sequus Pharm., Inc. (Infuturia I), No. C 08-4871 SBA, 2009 
WL 440477, at *2 (N.D. Cal. Feb. 23, 2009). 
37 Infuturia I, 2009 WL 440477, at *2. 
38 Defining stay as “[a]n order to suspend all or part of a judicial proceeding or a judgment 
resulting from that proceeding.” BLACK’S LAW DICTIONARY 1548 (9th ed. 2009); Infuturia II, 631 
F.3d at 1136; Infuturia I, 2009 WL 440477, at *2. 
39 Infuturia II, 631 F.3d at 1136. 
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Arbitrator Amnon Strashnov decided in favor of Yissum, granting 
its monetary claim and rejecting Infuturia’s cross claim.43  The arbitrator 
determined that the cancer drug was invented before Sequus received 
information from Yissum.44  A court in Israel confirmed the award.45
In 2008, after the Santa Clara County Superior Court lifted the stay 
on the litigation, Infuturia asked the court to confirm the Israeli arbitral 
award and filed a first amended complaint alleging tortious interference 
with the 1990 agreement, conspiracy to interfere with Infuturia’s rights 
under the 1990 agreement, conversion of Infuturia’s contract rights, 
breach of fiduciary duty, and fraudulent concealment.46  Thereafter, the 
University and Barenholz removed the case from the state court to the 
U.S. District Court for the Northern District of California under 9 U.S.C. 
§ 205.47  They argued that jurisdiction for the removed action existed 
under the Convention, as it provided the federal courts with the ability to 
“hear cases where the subject matter ‘relates to an arbitration . . . award 
falling under the Convention.’”48  The University and Barenholz asserted 
that Infuturia’s complaint related to the arbitration award since both 
parties sought to enforce portions of the award.49  Although they were 
non-signatories to the 1990 agreement containing the arbitration clause,50
the University and Barenholz intended to raise affirmative defenses in 
federal court, including collateral estoppel, arguing that the issues raised 
by Infuturia were decided in the Israeli arbitration.51
Infuturia filed a motion to remand the case back to Santa Clara 
County Superior Court since the defendants were non-signatories to the 
1990 agreement containing the arbitration provision.52  Nonetheless, the 
43 Brief of Appellant at 2, Infuturia II, 631 F.3d 1133 (No. 09-16378), 2009 WL 7113237 at 
*2; Infuturia I, 2009 WL 440477, at *2. 
44 Infuturia I, 2009 WL 440477, at *2. 
45 Id.
46 Id.
47 Infuturia Global Ltd. v. Sequus Pharm., Inc. (Infuturia II), 631 F.3d 1133, 1136 (9th Cir. 
2011). 
48 Defendants the Hebrew University of Jerusalem and Yechezkel Barenholz’ Memorandum 
of Points and Authorities in Opposition to Motion to Remand at 2, Infuturia I, 2009 WL 440477 
(No. C 08-4871 SBA), 2009 WL 1160328 at *2. 
49 Id.
50 Infuturia II, 631 F.3d 1135-36. 
51 Defining collateral estoppel as “[a] doctrine barring a party from relitigating an issue 
determined against that party in an earlier action, even if the second action differs significantly from 
the first one.” BLACK’S LAW DICTIONARY 298 (9th ed. 2009); Defendants the Hebrew University of 
Jerusalem and Yechezkel Barenholz’ Memorandum of Points and Authorities in Opposition to 
Motion to Remand at 2, Infuturia I, 2009 WL 440477 (No. C 08-4871 SBA), 2009 WL 1160328 at 
*2. 
52 Infuturia I, 2009 WL 440477, at *6; Infuturia II, 631 F.3d 1135-39. 
6
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district court found removal proper, thus denying the motion.53  In 
addition, the court found Infuturia’s pleadings were vague and ordered it 
to file a more specific second amended complaint.54
After Infuturia filed its Second Amended Complaint against only 
Sequus, the defendant answered and raised collateral estoppel as an
affirmative defense.55  Additionally, Sequus moved to dismiss under 
Federal Rule of Civil Procedure 12(b)(6), arguing that Infuturia had 
failed to state a claim, and under Rule 12(b)(7), arguing that Infuturia 
had failed to join a necessary party.56  The district court granted both 
motions, and Infuturia appealed.57
On appeal, Infuturia challenged the grant of Sequus’s motions to 
dismiss and the court’s subject matter jurisdiction, and argued that 
removal was inappropriate.58  A panel of the Ninth Circuit addressed the 
motion to dismiss in an unpublished disposition.59 In its published 
opinion the panel analyzed subject matter jurisdiction, removal 
jurisdiction, and timeliness of removal.60
IV. THE NINTH CIRCUIT’S ANALYSIS
A. SUBJECT MATTER JURISDICTION
Infuturia raised two arguments in support of its proposition that the 
federal courts lacked subject matter jurisdiction over the case.  First, 
Infuturia claimed that “the parties were not diverse when [the] case was 
removed.”61  The Ninth Circuit agreed with Infuturia’s argument that 
diversity did not exist initially, because there were foreign citizens on 
either side of the case at the time of removal.62  However, in its Second 
Amended Complaint, Infuturia had dismissed the foreign defendants.63
Consequently, the Ninth Circuit concluded that the district court had  
53 Infuturia II, 631 F.3d at 1136. 
54 Id.
55 Id.
56 Id.; see also FED. R. CIV. P. 12(b)(6), (7). 
57 Infuturia II, 631 F.3d at 1136. 
58 Id. at 1136, 1139. 
59 Id. at 1136 n.4. 
60 Id. at 1136-39. 
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diversity jurisdiction over the foreign appellant and the domestic 
appellee under 28 U.S.C. § 1332(a)(2).64
Second, Infuturia contended that jurisdiction was improper because 
even if Sequus had been the only defendant, it could not have removed 
the case to federal court given its position as the forum defendant.65  The 
Ninth Circuit rejected this argument, pointing out that because removal 
was effectuated under 9 U.S.C. § 205, the forum defendant rule was 
inapplicable.66
B. REMOVAL JURISDICTION
On the question of removal jurisdiction, the Ninth Circuit 
considered whether § 205 allowed for “removal jurisdiction over a case 
where the defendant raises an affirmative defense related to an arbitral 
award falling under the [Convention].”67
  The court identified the phrase 
“relates to” as the key language. 
To analyze that possibility, the 
Ninth Circuit first quoted § 205, which states in pertinent part that 
removal is permitted “[w]here the subject matter of an action or 
proceeding pending in a State court relates to an arbitration agreement or 
award falling under the Convention.”68
In its analysis of “relates to,” the Ninth Circuit looked at the Fifth 
Circuit’s interpretation of § 205, as well as how the term has been 
interpreted in other contexts.69  The Fifth Circuit construed the phrase to 
mean that, “whenever an arbitration agreement falling under the 
Convention could conceivably affect the outcome of the plaintiff’s case, 
the agreement ‘relates to’ the plaintiff’s suit.”70  The Ninth Circuit noted 
that, interpreting the phrase in context of the Employee Retirement 
Income Security Act, the Supreme Court said “[a] law ‘relates to’ an 
employee benefit plan, in the normal sense of the phrase, if it has a 
connection with or reference to such a plan.”71  And the Ninth Circuit 
noted that its own precedent interpreting the bankruptcy jurisdiction has 
64 Id.
65 Id.
66 Id.; see 9 U.S.C.A. § 205 (Westlaw 2011); 28 U.S.C.A. § 1441(b) (Westlaw 2011) 
(providing generally that unless the district court would have original jurisdiction based on the 
presence of a federal question, the action cannot be removed if one of the defendants is a citizen of 
the state in which the action is brought). 
67 Infuturia II, 631 F.3d at 1135 (footnote omitted). 
68 Id. at 1137 (quoting 9 U.S.C. § 205 and adding emphasis). 
69 Id. at 1137-38. 
70 Beiser v. Weyler, 284 F.3d 665, 669 (5th Cir. 2002). 
71 Infuturia II, 631 F.3d at 1138 (quoting Shaw v. Delta Air Lines, Inc., 463 U.S. 85, 96–97 
(1983)).
8
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held, like the Fifth Circuit’s interpretation of “relates to” in the context of 
9 U.S.C. § 205, that “[a] civil proceeding is ‘related to’ a [bankruptcy] 
case if the outcome of the proceeding could conceivably have any effect
on the estate being administered in bankruptcy.”72
Then, the Ninth Circuit examined Infuturia’s argument to add 
privity of contract to the § 205 analysis.73  Infuturia cited a Central 
District of California case holding that parties must have entered into an 
arbitration agreement (be in privity of contract) and the action had to 
relate to the arbitral agreement to remove the action from state court 
under § 205.74  The Ninth Circuit overruled that case, pointing out that 
adopting the proposed standard would base jurisdiction on the privity of 
the parties, whereas § 205 deals with the relationship between the arbitral 
agreement and the subject matter at issue.75
The Ninth Circuit concluded that “relates to” should be construed 
broadly, thereby rejecting Infuturia’s argument that 9 U.S.C. § 205 
should be narrowed by adding a privity requirement.76  As a result, the 
court found that Sequus’s collateral estoppel defense met the “relates to” 
standard because the Israeli arbitrator handed down an award that could 
conceivably affect the outcome of Infuturia Global Ltd. v. Sequus 
Pharmaceuticals, Inc.77
C. TIMELINESS OF REMOVAL
Finally, the Ninth Circuit rejected Infuturia’s assertion that removal 
was untimely.78  Section 205 permits defendants to, “at any time before 
the trial thereof, remove [an action falling under the Convention] to the 
district court.”79  The court denied Infuturia’s contention that the word 
“trial” means “any adjudication on the merits,” including the Israeli 
arbitration.80  Instead, the court emphasized that the statute clearly 
facilitated the removal of state court actions falling under the Convention 
at any time before the adjudication of the claims asserted in state court.81
72 Id. (quoting McGuire v. United States, 550 F.3d 903, 911–12 (9th Cir. 2008), with 
emphasis added and citation and internal quotation marks omitted). 
73 Id.
74 AtGames Holdings Ltd. v. Radica Games Ltd., 394 F. Supp. 2d 1252, 1255 (C.D. Cal. 
2005), overruled by Infuturia II, 631 F.3d at 1138-39. 
75 Infuturia II, 631 F.3d at 1138. 
76 Id.
77 Id. at 1138-39. 
78 Id. at 1139. 
79 9 U.S.C.A. § 205 (Westlaw 2011). 
80 Infuturia II, 631 F.3d at 1139. 
81 Id.
9
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Noting that the California superior court action remained undecided prior 
to removal, the Ninth Circuit rejected Infuturia’s argument that removal 
was not timely.82
V.  IMPLICATIONS OF THE DECISION
This decision is important because it provides parties in 
international arbitral disputes with ready access to the federal courts.  In
AtGames Holdings Ltd. v. Radica Games Ltd., the District Court for the 
Central District of California concluded that privity of contract was a 
necessary prerequisite to removal under 9 U.S.C. § 205.83  In Infuturia 
Global Ltd. v. Sequus Pharmaceuticals, Inc., Infuturia advanced a similar 
argument, and the Ninth Circuit rejected it outright.84
Other factors also contribute to the potential increase in cases heard by 
federal courts as a result of Infuturia Global.  In combination with these 
factors, the Infuturia Global decision may cause the federal courts to 
receive more § 205 notices of removal, to hear more motions to remand, 
and to retain more Convention cases. 
Instead, the Ninth 
Circuit explicitly agreed with existing Fifth Circuit precedent, making it 
easier to remove cases to the federal courts under the Convention.85
Because 9 U.S.C. § 203 provides original jurisdiction for cases that 
fall under the Convention,86 parties must meet only two criteria to 
remove an action under § 205.87  First, a party seeking to remove must 
establish that there is an arbitral award or agreement that falls under the
82 Id.
83 AtGames Holdings Ltd. v. Radica Games Ltd., 394 F. Supp. 2d 1252, 1255 (C.D. Cal. 
2005) (order granting motion to remand), overruled by Infuturia II, 631 F.3d at 1138–39. 
84 Infuturia II, 631 F.3d at 1138-39. 
85 Id. at 1138. 
86 9 U.S.C.A. § 203 (Westlaw 2011) (“An action or proceeding falling under the Convention 
shall be deemed to arise under the laws and treaties of the United States. The district courts of the 
United States . . . shall have original jurisdiction over such an action or proceeding, regardless of the 
amount in controversy.”).  As discussed in A.O.A. v. Doe Run Res. Corp., Nos. 4:11CV44 CDP, 
4:11CV45 CDP, 4:11CV46 CDP, 4:11CV47 CDP, 4:11CV48 CDP, 4:11CV49 CDP, 4:11CV50 
CDP, 4:11CV52 CDP, 4:11CV55 CDP, 4:11CV56 CDP, 4:11CV59 CDP, 2011 WL 2553259, at *3 
(E.D. Mo. June 22, 2011), 9 U.S.C. § 203 provides original jurisdiction for Convention cases in U.S. 
district courts. 
87 Hawkins v. KPMG LLP, 423 F. Supp. 2d 1038, 1044 (N.D. Cal. 2006) (order and 
memorandum granting motion to remand and denying motion to compel arbitration). 
10
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Convention.88  Second, the agreement or award must “relate to” the 
action.89  In most cases, these criteria will be easy to establish. 
The first prong of the test—that the award or agreement falls under 
the Convention—is simple to meet.  Section 202 identifies the 
agreements that fall under the Convention.90  A Ninth Circuit panel 
decision evaluated the plain meaning of § 202.91  According to the court, 
§ 202 confers jurisdiction on the district court when the agreement or 
award “(1). . . arise[s] out of a legal relationship (2) which is commercial 
in nature and (3) which is not entirely domestic in scope.”92  The court 
called these requirements “basic.”93
Similarly, in most cases, the second prong of the test should not 
prove difficult.  As discussed above, the Ninth Circuit interpreted the 
“relates to” language in § 205 broadly to mean the arbitral award or 
agreement need only “conceivably affect the outcome of the plaintiff’s 
suit” to be removable.94  In Beiser v. Weyler, the Fifth Circuit also 
broadly defined the “relates to” language from 9 U.S.C. § 205.95
According to the Fifth Circuit, 
[T]he district court will have jurisdiction under § 205 over just about 
any suit in which a defendant contends that an arbitration clause 
falling under the Convention provides a defense.  As long as the 
defendant’s assertion is not completely absurd or impossible, it is at 
least conceivable that the arbitration clause will impact the disposition 
of the case.  That is all that is required to meet the low bar of “relates 
to.”96
Both the Fifth and Ninth Circuits highlighted the ease with which 
defendants satisfy the second step by broadly defining the key phrase of 
§ 205.97
88 See 9 U.S.C.A. § 202 (Westlaw 2011) (“An arbitration agreement or arbitral award arising 
out of a legal relationship, whether contractual or not, which is considered as commercial, including 
a transaction, contract, or agreement . . . falls under the Convention.”). 
89 9 U.S.C.A. § 205 (Westlaw 2011). 
90 9 U.S.C.A. § 202. 




94 Infuturia Global Ltd. v. Sequus Pharm., Inc. (Infuturia II), 631 F.3d 1133, 1135 (9th Cir. 
2011). 
95 Beiser v. Weyler, 284 F.3d 665, 669 (5th Cir. 2002). 
96 Id. (emphasis added). 
97 Id.; Infuturia II, 631 F.3d at 1135, 1138. 
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Not only are the steps of the Convention removal process easy to 
satisfy, removal may provide defendants with significant advantages in 
some cases.98  Where federal procedural law differs from applicable 
state-court rules, the ability to remove may be outcome-determinative.99
Consequently, defendants may seek to remove actions to gain potential 
or perceived strategic advantages available in federal courts.100
In this era of global commercial transactions, international 
agreements often provide that disputes will be settled by arbitration 
rather than through the courts.101  In virtually every case where an 
arbitration agreement is at issue, and so long as the parties fall under the 
Convention and satisfy § 202, the federal courts will have jurisdiction on 
a showing that the arbitration award or agreement could conceivably
affect the outcome of the case.102
CONCLUSION
In AtGames Holdings v. Radica Games, the District Court for the 
Central District of California concluded that in order to rely upon an 
international arbitral agreement as the basis for removal under 9 U.S.C. § 
205, the defendant must have entered into the agreement with the 
plaintiff.103  In Infuturia Global Ltd. v. Sequus Pharmaceuticals, Inc.,
Infuturia advanced a similar argument, which the Ninth Circuit rejected 
outright.104  The court held that removal is permitted “whenever an 
arbitration agreement . . . could conceivably affect the outcome of the 
plaintiff’s case.”   Since the Ninth Circuit’s § 205 removal standard is 
now lower, defendants may use the Infuturia Global decision to remove 
more cases, giving them the potential advantages of litigating in federal 
105
98 See, e.g., SAMUEL ISSACHAROFF, CIVIL PROCEDURE 135-36 (2d ed. 2008) (stating many of 
the strategic considerations that plaintiffs ponder in deciding upon a forum, and that may be lost 
when an action is removed). 
99 See id.; see also Hanna v. Plumer, 380 U.S. 460, 473-74 (1965); Erie v. Tompkins, 304 
U.S. 64, 78 (1938).
100 SAMUEL ISSACHAROFF, CIVIL PROCEDURE 135 (2d ed. 2008). 
101 Christopher R. Drahozal, Commercial Norms, Commercial Codes, and International 
Commercial Arbitration, 33 VAND. J. TRANSNAT’L L. 79, 94 (2000) (stating that arbitration is 
accepted as the form of dispute resolution for international business, and that one estimation was that 
“ninety percent of all international contracts contain arbitration clauses”). 
102 Id. (stating one estimation that “ninety percent of all international contracts contain 
arbitration clauses”). 
103 AtGames Holdings Ltd. v. Radica Games Ltd., 394 F. Supp. 2d 1252, 1255 (C.D. Cal. 
2005) (order granting motion to remand), overruled by Infuturia Global Ltd. v. Sequus Pharm., Inc. 
(Infuturia II), 631 F.3d 1133 (9th Cir. 2011). 
104 Infuturia II, 631 F.3d at 1138-39. 
105 Id. at 1138. 
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court.  Thus, the Ninth Circuit’s interpretation of 9 U.S.C. § 205 will 
inevitably result in more cases on the federal courts’ dockets. 
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